The interplay of maturity-onset diabetes of the young, obesity, uncontrolled hypertension, and cannabinoid hyperemesis in the progression to end-stage renal disease: a case report - Scorecard - MDSpire

The interplay of maturity-onset diabetes of the young, obesity, uncontrolled hypertension, and cannabinoid hyperemesis in the progression to end-stage renal disease: a case report

  • By

  • Neguemadji Ngardig Ngaba

  • Victoria Lovallo

  • Anna ONeil

  • Xegfred Lou T. Quidet

  • Michael Asare

  • Henry Nabeta

  • Shagun Thakur

  • Riddick Osei Agyemang

  • Rayan Alataa

  • Fouad Kaddour Hocine

  • Karla Garcia Rodriguez

  • Abel Akanyijuka

  • Dennis Ansah

  • Akua Amoa

  • Oserefuamen Okobi

  • Shazia Khan

  • Ruchita Kodakandla

  • Sahil Dudhat

  • Shrushti Tanna

  • Del Orbe Eduardo

  • Muhammad Saleem Akhter

  • Rabih Nasr

  • Kalpana Uday

  • Khaja Misbahuddin

  • May 1, 2026

  • 0 min

Share

Clinical Scorecard: Factors Contributing to End-Stage Renal Disease in a Young Patient with Maturity-Onset Diabetes of the Young, Obesity, Uncontrolled Hypertension, and Cannabinoid Hyperemesis: A Case Study

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationYoung adults (ages 18-30) with MODY, obesity, and chronic cannabis use.
Care Setting

Key Highlights

  • Add details on comorbidities and treatment timeline.

Guideline-Based Recommendations

Diagnosis

    Management

    • Implement comprehensive management strategies for diabetes, hypertension, and obesity, referencing ADA guidelines.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clarify the rationale for combination therapy and expected outcomes.

        Clinical Best Practices

        • Specify involved specialties in the multidisciplinary approach.

        References

        Original Source(s)

        The interplay of maturity-onset diabetes of the young, obesity, uncontrolled hypertension, and cannabinoid hyperemesis in the progression to end-stage renal disease: a case report

        • by Neguemadji Ngardig Ngaba, Victoria Lovallo, Anna ONeil, Xegfred Lou T. Quidet, Michael Asare, Henry Nabeta, Shagun Thakur, Riddick Osei Agyemang, Rayan Alataa, Fouad Kaddour Hocine, Karla Garcia Rodriguez, Abel Akanyijuka, Dennis Ansah, Akua Amoa, Oserefuamen Okobi, Shazia Khan, Ruchita Kodakandla, Sahil Dudhat, Shrushti Tanna, Del Orbe Eduardo, Muhammad Saleem Akhter, Rabih Nasr, Kalpana Uday, Khaja Misbahuddin

        • May 1, 2026

        Related Content

        Editorial: Modifiable risk factors for chronic kidney disease progression

        24-hour diastolic blood pressure average real variability predicts renal progression in diabetic kidney disease: a comprehensive cohort study

        A Systematic Review and Network Meta-Analysis of Chinese Trials on Antihypertensive Medications for Managing Hyperuricemia in Hypertensive Patients